
Kapisthalam S. Kumar, MD
Medical Oncology in Hudson, FL
- Enrolled in Medicare
- Accepts Medicare assignment
- 51 years since graduation
- Public record — not managed by the clinician
About Dr. Kapisthalam Kumar
Dr. Kapisthalam Kumar is a physician specializing in medical oncology practicing in Hudson, FL. Records list 2 practice addresses. Affiliated with Hca Florida Bayonet Point Hospital, Hca Florida Trinity Hospital. Treated 467 Medicare patients in 2024.
- Medical Oncology
- Florida Cancer Specialists & Research Institute, LLC
- Accepts Medicare assignment
- In-person visits at 2 addresses
Provider details
| Specialty | Medical OncologyOther medical oncology doctors in Hudson |
|---|---|
| Credentials | MD |
| Gender | Male |
| NPI number | 1255335758National Provider Identifier (CMS NPPES), issued June 2005 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Dr. Kapisthalam Kumar's specialties and state licenses
- Medical Oncology Primary
License: FL 67089 - Hematology
License: FL 67089
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Where Dr. Kapisthalam Kumar practices
-
Florida Cancer Specialists & Research Institute, LLC 14100 Fivay Rd, Suite 380, Hudson, FL 34667 (727) 862-9026 Group of 496 clinicians Directions Call office View clinic details -
Florida Cancer Specialists & Research Institute, LLC 14529 Cortez Blvd, Brooksville, FL 34613 (352) 596-1402 Group of 496 clinicians Directions Call office View clinic details
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Hospital affiliations of Dr. Kapisthalam Kumar
- Hca Florida Bayonet Point HospitalHospital · Hudson, FL
- Hca Florida Trinity HospitalHospital · Trinity, FL
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Kapisthalam Kumar's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.
Dr. Kapisthalam Kumar's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,478 | $7.59 |
| Insertion of needle into vein for collection of blood sample | 1,427 | $8.65 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 666 | $87.54 |
| Injection of additional new drug or substance into vein | 476 | $14.51 |
| Injection of drug or substance under skin or into muscle | 367 | $13.71 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 340 | $122.82 |
| Administration of chemotherapy into vein, 1 hour or less | 248 | $120.97 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 225 | $58.84 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Payments from drug and device companies to Dr. Kapisthalam Kumar (2025)
$4,448.43 in 197 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 196 | $4,436.01 |
| Education | 1 | $12.42 |
Paying companies: Merck Sharp & Dohme LLC ($379.85), AstraZeneca Pharmaceuticals LP ($294.59), Incyte Corporation ($277.44), Pfizer Inc. ($271.33), AbbVie Inc. ($256.90), NOVARTIS PHARMACEUTICALS CORPORATION ($247.98).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Also at Florida Cancer Specialists & Research Institute, LLC
- Ramya Pinnamaneni, MDHematology/oncology Florida Cancer Specialists & Research Institute, LLC
- Huayang Tang, MDHematology/oncology Florida Cancer Specialists & Research Institute, LLC
- Arthur J. Matzkowitz, MDRadiation Oncology Florida Cancer Specialists & Research Institute, LLC
- James C. Wert, DOMedical Oncology Florida Cancer Specialists & Research Institute, LLC
- Deborah Hawkins, ARNPNurse Practitioner Florida Cancer Specialists & Research Institute, LLC
Questions about Dr. Kapisthalam Kumar
What kind of clinician is Dr. Kapisthalam Kumar?
Dr. Kapisthalam Kumar is listed as a physician specializing in medical oncology.
Where does Dr. Kapisthalam Kumar practice?
Florida Cancer Specialists & Research Institute, LLC at 14100 Fivay Rd, Suite 380, Hudson, FL 34667, and 1 other address in the records.
What is the office phone number for Dr. Kapisthalam Kumar?
The listed office number is (727) 862-9026. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Kapisthalam Kumar?
The National Provider Identifier is 1255335758.
Does Dr. Kapisthalam Kumar accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Kapisthalam Kumar affiliated with?
Hca Florida Bayonet Point Hospital, Hca Florida Trinity Hospital.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2022-08-10 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.
Need an appointment?
Call Florida Cancer Specialists & Research Institute, LLC at (727) 862-9026 or visit the clinic page to check availability.